Predisposing and Protective Factors of Endometriosis

9.
Bulun, S. E. (2009). Endometriosis. The New England Journal of Medicine, 360(3), 268–279.CrossRefPubMed
10.
Jabbour, H. N., Sales, K. J., Smith, O. P., Battersby, S., & Boddy, S. C. (2006). Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Molecular and Cellular Endocrinology, 252(1–2), 191–200.CrossRefPubMed
11.
Maia, H., Jr., Haddad, C., & Casoy, J. (2012). Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis. International Journal of Women’s Health, 4, 61–65.PubMedCentralCrossRefPubMed
12.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996). Aromatase expression in endometriosis. The Journal of Clinical Endocrinology and Metabolism, 81(1), 174–179.PubMed
13.
Harada, T., Iwabe, T., & Terakawa, N. (2001). Role of cytokines in endometriosis. Fertility and Sterility, 76(1), 1–10.CrossRefPubMed
14.
Hsu, C. C., Yang, B. C., Wu, M. H., & Huang, K. E. (1997). Enhanced interleukin-4 expression in patients with endometriosis. Fertility and Sterility, 67(6), 1059–1064.CrossRefPubMed
15.
Christodoulakos, G., Augoulea, A., Lambrinoudaki, I., Sioulas, V., & Creatsas, G. (2007). Pathogenesis of endometriosis: The role of defective ‘immunosurveillance’. The European Journal of Contraception & Reproductive Health Care, 12(3), 194–202.CrossRef
16.
Giudice, L. C., & Kao, L. C. (2004). Endometriosis. Lancet, 364(9447), 1789–1799.CrossRefPubMed
17.
Kyama, C. M., Debrock, S., Mwenda, J. M., & D’Hooghe, T. M. (2003). Potential involvement of the immune system in the development of endometriosis. Reproductive Biology and Endocrinology, 1, 123.PubMedCentralCrossRefPubMed
18.
Donnez, J., Smoes, P., Gillerot, S., Casanas-Roux, F., & Nisolle, M. (1998). Vascular endothelial growth factor (VEGF) in endometriosis. Human Reproduction (Oxford, England), 13(6), 1686–1690.CrossRef
19.
May, K. E., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2011). Endometrial alterations in endometriosis: A systematic review of putative biomarkers. Human Reproduction Update, 17(5), 637–653.CrossRefPubMed
20.
Gennings, C., Sabo, R., & Carney, E. (2010). Identifying subsets of complex mixtures most associated with complex diseases: Polychlorinated biphenyls and endometriosis as a case study. Epidemiology, 21(Suppl 4), S77–S84.CrossRefPubMed
21.
Asante, A., & Taylor, R. N. (2011). Endometriosis: The role of neuroangiogenesis. Annual Review of Physiology, 73, 163–182.CrossRefPubMed
22.
Berkkanoglu, M., & Arici, A. (2003). Immunology and endometriosis. American Journal of Reproductive Immunology, 50(1), 48–59.CrossRefPubMed
23.
Oosterlynck, D. J., Cornillie, F. J., Waer, M., Vandeputte, M., & Koninckx, P. R. (1991). Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertility and Sterility, 56(1), 45–51.PubMed
24.
Wu, M. H., Yang, B. C., Lee, Y. C., Wu, P. L., & Hsu, C. C. (2004). The differential expression of intercellular adhesion molecule-1 (ICAM-1) and regulation by interferon-gamma during the pathogenesis of endometriosis. American Journal of Reproductive Immunology, 51(5), 373–380.CrossRefPubMed

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 25, 2017 | Posted by in GYNECOLOGY | Comments Off on Predisposing and Protective Factors of Endometriosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access